Screener
Solid Biosciences Inc. SLDB Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Solid Biosciences Inc.’s 10-K, filed March 19, 2026.
- Filed
- Mar 19, 2026, 4:01 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-115928
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 |
|---|---|---|
| Loss from operations | (179,206) | (129,728) |
| Other income, net: | ||
| Interest income | 9,904 | 9,469 |
| Interest expense | 203 | (340) |
| Change in fair value of derivative liabilities | (6,050) | (4,750) |
| Other income, net | 824 | 652 |
| Total other income, net | 4,881 | 5,031 |
| Net loss | $(174,325) | $(124,697) |
Item 16. Form 10-K Summary.
FAQ
- What is Solid Biosciences Inc.'s interest expense?
- Solid Biosciences Inc. (SLDB) reported interest expense of $0 in Q4 2025.
- How has Solid Biosciences Inc.'s interest expense changed year-over-year?
- Solid Biosciences Inc.'s interest expense decreased by 100.0% year-over-year, from $75K to $0.
- What is the long-term trend for Solid Biosciences Inc.'s interest expense?
- Over 2 years (2023 to 2025), Solid Biosciences Inc.'s interest expense has grown at a -31.2% compound annual growth rate (CAGR), from $439K to -$208K.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Solid Biosciences Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude